A phase II study assessing the potential of Disufenton/acetylcysteine to treat and prevent hearing loss
Latest Information Update: 14 Feb 2020
At a glance
- Drugs Disufenton/acetylcysteine (Primary)
- Indications Hearing loss
- Focus Therapeutic Use
Most Recent Events
- 14 Feb 2020 New trial record